Byers Capital
Funding rounds backed by Byers Capital.
- Funding disclosed in full
- $21M
- Median round
- $21M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Oryon Cell Therapies Develops autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders | $21MSeries A | BiotechUnited States |